• Users Online: 747
  • Print this page
  • Email this page

  Table of Contents  
Year : 2018  |  Volume : 9  |  Issue : 1  |  Page : 20-26  

Mucocutaneous manifestations in patients with chronic kidney disease: A cross-sectional study

1 Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, Himachal Pradesh, India
2 Department of Internal Medicine, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra, Himachal Pradesh, India

Date of Web Publication22-Jan-2018

Correspondence Address:
Vikram K Mahajan
Department of Dermatology, Venereology and Leprosy, Dr. R. P. Govt. Medical College, Kangra - 176 001, Himachal Pradesh
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/idoj.IDOJ_160_17

Rights and Permissions

Background: Chronic kidney disease (CKD)-associated mucocutaneous manifestations significantly impair the quality of life but often remain understudied. They may also vary across regions, socioeconomic and nutritional status, and racial differences. Objectives: To study the patterns of mucocutaneous disorders and their prevalence in CKD patients irrespective of clinical stage or dialysis status. Materials and Methods: 122 (M:F = 77:45) patients aged 21‒85 (Mean ± SD = 57.5 ± 14.0) years having CKD for 3 month to 5 years were studied for mucocutaneous manifestations. Fifty (41%) patients were on hemodialysis for 1‒42 months. Detailed medical history, clinical and mucocutaneous examination, and lab investigations were performed. KOH mounts, skin biopsy, Gram's and Giemsa staining, bacterial or fungal cultures were performed as required. Results: Xerosis in 93 (76.2%), skin pallor in 61 (50%), pruritus in 57 (46.7%), pigmentation in 47 (38.5%), and purpura in 18 (14.8%) patients were the major dermatoses. Bullous lesions and perforating folliculitis occurred in 3 (2.5%) patients each. Major nail abnormalities were pallor (in 35.2%), absent lunula (in 23.8%), nail discoloration (in 18%), and “half-and-half nails” in 16.4% patients, respectively. Hair abnormalities included sparse scalp and body hairs (in 35.2% and 13.1%, respectively) and lusterless hair in 12.3% patients. Coated tongue (in 14.8%), xerostomia (in 12.3%), and macroglossia with teeth indention (in 7.4%) patients were the mucosal manifestations. Conclusions: Xerosis, pruritus, skin pallor/pigmentary changes, nail pallor, absent lunula, nail discoloration, sparse hairs, coated tongue, xerostomia, macroglossia, and infections were the most common mucocutaneous manifestations in the studied patients irrespective of hemodialysis status. Cold and dry climates might be additional aggravators for xerosis/pruritus. Lifelong follow-up may be needed to reduce the morbidity associated with CKD/hemodialysis specific dermatoses appearing over a period.

Keywords: Cutaneous manifestations, end-stage renal disease, skin diseases

How to cite this article:
Rashpa RS, Mahajan VK, Kumar P, Mehta KS, Chauhan PS, Rawat R, Sharma V. Mucocutaneous manifestations in patients with chronic kidney disease: A cross-sectional study. Indian Dermatol Online J 2018;9:20-6

How to cite this URL:
Rashpa RS, Mahajan VK, Kumar P, Mehta KS, Chauhan PS, Rawat R, Sharma V. Mucocutaneous manifestations in patients with chronic kidney disease: A cross-sectional study. Indian Dermatol Online J [serial online] 2018 [cited 2021 Aug 1];9:20-6. Available from: https://www.idoj.in/text.asp?2018/9/1/20/223715

   Introduction Top

Chronic kidney disease (CKD) is an irreversible deterioration in renal function classically developing over years and is defined as kidney damage or glomerular filtration rate <60 ml/min/1.73 m2 for 3 months or more irrespective of the cause.[1] Most patients with severe CKD progress to end-stage renal disease (ESRD) with significant morbidity and mortality. It is a worldwide problem and accounts for approximately 850,000 deaths every year and 15 million disability adjusted lives; ESRD is the 12th cause of death and 17th cause of disability globally.[2] Cutaneous manifestations are common in all stages of CKD particularly towards ESRD with a prevalence of 50–100%.[3],[4] With the advent of hemodialysis as a therapeutic modality for ESRD, some skin manifestations such as uremic frost and erythema papulatum uremicum have become rare, however, many other abnormalities of skin and appendages have emerged. Skin manifestations specific to dialysis patients include acquired perforating dermatosis, calcific uremic arteriolopathy (calciphylaxis), bullous lesions, and nephrogenic fibrosing dermopathy. On the other hand, pruritus, xerosis, nail disorders, hair disorders, pigmentary changes, purpura, mucosal changes, pallor, and uremic frost, though not specific to hemodialysis, are more frequent. However, it may be difficult to implicate either CKD or hemodialysis alone for any particular cutaneous manifestation as many of them are associated with both.[5] These manifestations may also vary across regions, with individual dietary habits, socioeconomic and nutritional status, and racial differences.[6] Because there are no data on the pattern of mucocutaneous manifestations in CKD patients from this part of the country, this study was carried out.

   Patients and Methods Top

This study included 122 consecutive CKD patients aged ≥18 years recruited from the renal unit under internal medicine during April 2015 to March 2016. The study was approved by the Institutional Scientific Protocol Review Committee and Institutional Ethics Committee. All enrolled patients participated after providing informed written consent. Human immunodeficiency (HIV)-affected persons, renal transplant recipients, and patients with acute renal failure, hepatobiliary, pancreatic, or thyroid disorders, cutaneous, or systemic malignancies were excluded. Details of medical history, clinical and mucocutaneous findings, and investigations were recorded. KOH mounts, skin biopsy, Gram's and Giemsa staining, and bacterial or fungal cultures were performed when needed. The diagnosis and clinical staging of CKD was as per the National Kidney Foundation severity assessment criteria, and the severity of pruritus and xerosis was graded as mild, moderate, and severe [Table 1].[1],[7],[8] The data was analyzed using Pearson's Chi Square and Fischer's exact tests for categorical variables, and the Mann–Whitney nonparametric test was used for other variables that were not distributed normally. P < 0.05, calculated at the 5% level (95% confidence limit) was considered statistically significant.
Table 1: Staging of chronic kidney disease and severity grading of pruritus and xerosis

Click here to view

   Results Top

[Table 2] depicts the baseline characteristics of patients comprising 77 men and 45 women (M:F = 1.7:1) aged between 21 and 85 (mean ± SD = 57.5 ± 14.0) years having CKD for 3 months to 5 years. Fifty (41%) patients were on hemodialysis for 1‒42 (mean ± SD = 9.3 ± 9.0) months. The blood urea levels ranged from 100 to 280 mg/dl in 92 (75.4%) patients. Hemoglobin was between 4.5 and 12 g/dl in 120 (98.4%) patients. One or more mucocutaneous disorders occurred in 120 (98.3%) patients [Table 3] and [Table 4].
Table 2: Baseline characteristics of patients with chronic renal disease

Click here to view
Table 3: Cutaneous and mucosal manifestations in patient with chronic renal disease

Click here to view
Table 4: Hair and nail disorders in chronic renal disease patients

Click here to view

Xerosis in 93 (76.2%) patients, severe and ichthyotic in 10 (8.2%) patients, and pruritus of mild to severe intensity in 57 (46.7%) patients were the most common manifestations. The pruritus intensity was mild to moderate in 52 (55.9%) patients with xerosis. Photodistributed hyperpigmentation in 47 (38.5%), skin pallor in 61 (50%), yellow-tinged skin in 7 (5.7%), and purpura/ecchymosis in 18 (14.8%) patients were present. Tense bullae over toes [Figure 1] and perforating folliculitis [Figure 2] were noted in 3 (2.5%) patients each who were also diabetic. Four (3.3%) patients aged 36‒43 years had facial wrinkling. One patient, a diabetic and on hemodialysis for 3 months, had a nonhealing ulcer on the right foot. Mucosal abnormalities occurred in 48 (39.3%) patients and in the order of frequency were coated tongue in 18 (14.8%), xerostomia in 15 (12.3%), macroglossia with teeth markings [Figure 3], and fissured tongue in 9 (7.4%) patients each, angular cheilitis in 5 (4.1%), and aphthous stomatitis and black pigmented tongue [Figure 4] in 2 (1.6%) patients each. Hair abnormalities in 55 (45.1%) patients included sparse scalp and body hairs and lusterless hairs in 45 (35.2%), 16 (13.1%), and 15 (12.3%) patients, respectively. Nail changes in 91 (74.6%) patients comprised nail pallor in 43 (35.2%), absent lunula in 29 (23.8%), nail discoloration in 22 (18%), and Lindsay's “half-and-half nails” [Figure 5] in 20 (16.4%) patients. Other nail changes included longitudinal ridging in 13 (10.7%), subungual hyperkeratosis in 11 (9%), onycholysis in 10 (8.2%), dystrophic nails in 7 (5.7%), Beau's lines in 6 (4.9%), and koilonychia in 5 (4.1%) patients, respectively. Statistically, patients on hemodialysis were older, had longer duration of CKD, skin and nail pallor, elevated blood urea levels, and low hemoglobin (mean ± SD = 7.2 ± 0.8 g/dl) than patients without hemodialysis, and the difference was statistically significant (P < 0.05). [Table 5] lists various bacterial, fungal, and viral infections noted in 59 (48.4%) patients.
Figure 1: Large tense bullae over toes in a patient with diabetic nephropathy

Click here to view
Figure 2: Perforating folliculitis with keratotic papules over (a) leg (b) abdomen. Note severe ichthyotic skin over trunk

Click here to view
Figure 3: White coated tongue and Macroglossia with prominent teeth markings, the characteristic “tongue sign of uremia”

Click here to view
Figure 4: Black pigmentation of tongue

Click here to view
Figure 5: Lindsay's “half and half nails” - a characteristic colored band over distal nail plate and pale proximal nail plate

Click here to view
Table 5: Cutaneous infections in patient with chronic renal disease

Click here to view

   Discussion Top

Clinicodemographic profile of our patients is similar to previous reports.[6],[9],[10],[11],[12],[13],[14],[15] Xerosis of variable severity is well known in 23–90% patients irrespective of dialysis status.[6],[9],[10],[16] Skin dehydration, diuretics, hypervitaminosis A, reduced sebum/sweat excretion, altered skin barrier, and low emollient usage have been primarily implicated for severity of xerosis whereas marked irritancy to external factors (sun, dust, detergents) is aggravating.[5],[9],[17],[18],[19] However, prevailing dry and cold climate in this region was an additional aggravating factor in our patents. In addition to pruritus, associated with xerosisis is elastosis and premature skin wrinkling in 33–40% patients.[13],[14],[19] Only 4 (3.3%) patients showed early skin wrinkling in this study. Generalized or localized, episodic or continuous pruritus of variable intensity is frequent in CKD. It may or may not improve from hemodialysis and occurs in 15–49% during predialysis and in 19–90% hemodialysis patients.[4],[9],[8],[11] The pruritus was mild to severe in our 57 (46.7%) patients. However, there was no significant difference among patients with or without hemodialysis. The pathogenesis of uremic pruritus is poorly understood but its intensity is directly proportional to the severity of xerosis.[19] The pruritus of mild to moderate intensity correlated to xerosis severity in our 52 (55.9%) patients. Sun-exposed skin hyperpigmentation observed in 47 (38.5%) CKD and 48% of the hemodialysis patients corroborated the reported prevalence of 22–54% patients correlating to the duration of dialysis as well.[9],[16] It is mostly attributed to excessive melanin in basal layer and superficial dermis from increased poorly dialyzable β-melanocyte-stimulating hormone.[3],[4],[9],[13],[16]

Yellow-tinged skin in 40% CKD patients is attributed to retained lipid soluble pigments in dermis/subcutis.[4] However, it was noticed in our 7 (5.7%) patients only possibly due to poor appreciation of this subtle color against our dark-skin (type-V) patients. Anemia occurs in 34–94.3% CKD patients mainly from decreased renal erythropoietin, iron, folic acid, or vitamin B12 deficiency, poor erythrocyte survival, and blood loss during dialysis.[11],[13],[16] Skin pallor in 61 (50%) patients was apparently from anemia and was significantly more common among patients on hemodialysis (P < 0.05). Purpura, ecchymosis, and petechiae reportedly occurred in 9–20%, 27%, and 19% CKD patients on hemodialysis, respectively, but said to improve after hemodialysis.[11],[14],[16] Increased vascular fragility and platelet dysfunction from high blood urea levels or heparin use during dialysis have been implicated. Purpura and ecchymosis in our 18 (14.8%) patients with blood urea levels above 100 mg/dl corroborated but did not correlate with hemodialysis status. Bullae (dialysis-pseudoporphyria) possibly from transfusion-related iron overload usually affect 2–18% patients.[5],[17] However, diabetic or uremic neuropathy causing blisters in 3 (2.5%) patients unrelated to hemodialysis status also remain a possibility. Perforating folliculitis of unclear pathophysiology is significantly common among diabetic CKD patients.[11] Similarly, these patients are at an increased risk of foot ulcer/amputation primarily from peripheral neuropathy.[20] The perforating folliculitis in 3 (2.5%) patients and nonhealing foot ulcer in a diabetic patient on hemodialysis for 3 months also corroborates these findings.[9],[11],[13],[14]

Coated tongue in 18 (14.8%) and xerostomia in 15 (12.3%) patients were the most common mucosal abnormalities. Macroglossia with teeth markings in 9 (7.4%) patients usually affects 9–43% cases and is considered characteristic of uremia.[13],[15] Although fissured tongue affects 4–8% CKD patients and also up to 20% of the general population, its pathogenesis and significance in CKD remains poorly elucidated.[6],[12] Agreeably, nutritional deficiencies, candidiasis, poor oral hygiene, smoking, consumption of alcohol or hot/spicy foods, dehydration, and mouth breathing remain overall possible pathogenetic triggers.[13],[14]

Nail pallor in 43 (35.2%) patients having anemia was the most common finding corroborating its reported prevalence of 67% CKD and 96% patients on hemodialysis.[10],[21] Absent lunula observed in 29 (23.8%) patients reportedly occurs in 17–63% patients irrespective of dialysis status.[13] Other consistent nail change characteristic of CKD with or without dialysis is Lindsay's “half-and-half nails,” a band of discoloration over the distal nail plate from increased density of nail bed capillaries, with a reported prevalence of 17–76%.[11],[22] Comparatively, we noted “half and half nails” in 20 (16.4%) patients including among those on hemodialysis. Sparse scalp and body hairs in 45 (35.2%) and 16 (13.1%), and lusterless hairs in 15 (12.3%) patients, respectively, seen in our patients corroborates their reported prevalence of 30–70%.[10],[16],[22] Apparently, reduced sebum production and parathormone levels, anemia, stress of ESRD/dialysis, or neglecting hair care could be implicated.[11],[13],[14],[22] The 28–70% CKD patients also have increased susceptibility for bacterial, fungal, and viral cutaneous infections due to reduced immunity.[4],[13],[23] In this study, 59 (48.4%) patients with or without hemodialysis also suffered these infections. More CKD/hemodialysis-specific dermatoses probably appear over a period.

   Conclusion Top

Xerosis, pruritus, skin pallor/pigmentary changes, nail pallor, absent lunula, nail discoloration, sparse hairs, coated tongue, xerostomia and macroglossia, and infections were the most common mucocutaneous manifestations in majority of studied patients irrespective of their hemodialysis status. Cold and dry climates might be additional aggravators for xerosis/pruritus. Lifelong follow-up is needed to reduce the morbidity from dermatoses considered CKD/hemodialysis specific that may appear over time. Short duration and the cross-sectional nature of the study are some of the limitations of this study.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

   References Top

Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, et al. Definition and classification of chronic kidney disease: A position statement from kidney disease: Improving global outcomes (KDIGO). Kidney Int 2005;67:2089-100.  Back to cited text no. 1
Prabhakar MR, Chandrasekaran V, Soundarajan P. Epidemic of chronic kidney disease in India-what can be done? Saudi J Kidney Dis Transpl 2008;19:847-53.  Back to cited text no. 2
Nunley JR. Dermatological manifestations of renal disease. Available from: http//emedicine.medscape.com/article/1094846-overview. [Last accessed on 2014 Dec 12].  Back to cited text no. 3
Pico MR, Lugo Somolinos A, Sanchez JL, Burgos Calderon R. Cutaneous alterations in patients with chronic renal failure. Int J Dermatol 1992;31:860-3.  Back to cited text no. 4
Abdelbaqi-Salhab M, Shalhub S, Morgan MB. A current review of the cutaneous manifestations of renal disease. J Cutan Pathol 2003;30:527-38.  Back to cited text no. 5
Hajheydari Z, Makhlough A. Cutaneous and mucosal manifestations in patients on maintenance hemodialysis: A study of 101 patients in Sari, Iran. Iran J Kidney Dis 2008;2:86-90.  Back to cited text no. 6
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.  Back to cited text no. 7
Akhyani M, Ganji MR, Samadi N, Khamesan B, Daneshpazhooh M. Pruritus in hemodialysis patients. BMC Dermatol 2005;5:7.  Back to cited text no. 8
Khanna D, Singal A, Kalra OP. Comparison of cutaneous manifestations in chronic kidney disease with or without dialysis. Postgrad Med J 2010;86:641-7.  Back to cited text no. 9
Mirza R, Wahid Z, Talat H. Dermatologic manifestations in chronic renal failure patients on hemodialysis. J Liaquat Uni Med Health Sci 2012;11:24-8.  Back to cited text no. 10
Udayakumar P, Balasubramanian S, Ramalingam KS, Lakshmi C, Shrinivas CR, Mathew AC. Cutaneous manifestations in patients with chronic renal failure on hemodialysis. Indian J Dermatol Venereol Leprol 2006;72:119-25.  Back to cited text no. 11
[PUBMED]  [Full text]  
Tajbakhsh R, Dehghan M, Azarhoosh R, Haghighi AN, Sadani S, Zadeh SS, et al. Mucocutaneous manifestations and nail changes in patients with end stage renal disease on hemodialysis. Saudi J Kidney Dis Transpl 2013;24:36-40.  Back to cited text no. 12
[PUBMED]  [Full text]  
Sanad EM, Sorour NE, Saudi WM, Elmasry AM. Prevalence of cutaneous manifestations in chronic renal failure patients on regular hemodialysis: A hospital based study. Egyptian J Dermatol Venereol 2014;34:27-35.  Back to cited text no. 13
Sultan MM, Mansour HH, Wahby IM, Houdery AS. Cutaneous manifestations in Egyptian patients with chronic renal failure on regular hemodialysis. J Egypt Women Dermatol Soc 2010;7:49-55.  Back to cited text no. 14
Thomas EA, Powar B, Thomas A. A prospective study of cutaneous abnormalities in patients with chronic kidney disease. Indian J Nephrol 2012;22:116-20.  Back to cited text no. 15
  [Full text]  
Shah A, Hada R, Kayastha BM. Dermatological disorders in chronic kidney disease with and without maintenance hemodialysis. JNMA J Nepal Med Assoc 2013;52:365-71.  Back to cited text no. 16
Lupi O, Rezende L, Zangrando M, Sessim M, Silveira CB, Sepulcri MA, et al. Cutaneous manifestations in end stage renal disease. An Bras Dermatol 2011;86:319-26.  Back to cited text no. 17
Petkov T, Dencheva R, Tsankov N. Skin changes of patients on dialysis treatment. J Turk Acad Dermatol 2010;4:04301r.  Back to cited text no. 18
Szepietowski JC, Reich A, Schwartz RA. Uremic xerosis. Nephrol Dial Transplant 2004;19:2709-12.  Back to cited text no. 19
Kaminski M, Frescos N, Tucker S. Prevalence of risk factors for foot ulceration in patients with end-stage renal disease on haemodialysis. Intern Med J 2012;42:e120-8.  Back to cited text no. 20
Levillard DT, Kambil SM. Cutaneous manifestations in chronic renal disease-an observational study of skin changes, new findings, their association with hemodialysis, and their correlation with severity of CKD. Int J of Sci Res Pub 2015;5:727-36.  Back to cited text no. 21
Mourad B, Hegab D, Okasha K, Rizk S. Prospective study on prevalence of dermatological changes in patients under hemodialysis in hemodialysis units in Tanta University hospitals, Egypt. Clin Cosmet Investig Dermatol 2014;7:313-9.  Back to cited text no. 22
Headley CM, Wall B. ESRD-associated cutaneous manifestations in a hemodialysis population. Nephrol Nurs J 2002;29:525-7.  Back to cited text no. 23


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5]

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
   Patients and Methods
    Article Figures
    Article Tables

 Article Access Statistics
    PDF Downloaded490    
    Comments [Add]    

Recommend this journal